Short review of SEC, a potential dexamethasone-sparing regimen for glioblastoma: Spironolactone, ecallantide, clotrimazole
| Autor: | Kast, R.E. *, Burns, T.C., Halatsch, M.-E. |
|---|---|
| Zdroj: | In Neurochirurgie September 2021 67(5):508-515 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect